Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Forni

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gene|January 13, 2006
The Pole3 bidirectional unit is regulated by MYC and E2FsFabrizio Bolognese, Claudia Forni, Giuseppina Caretti, et al.
Cell|January 22, 2013
Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitinationMarco Nardini, Nerina Gnesutta, Giacomo Donati, et al.
Molecular Cancer Therapeutics|January 24, 2007
Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamideDaniel Hochhauser, Minal Kotecha, Caroline O'hare, et al.
Molecular Cancer Therapeutics|May 17, 2008
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78Minal Kotecha, Jerome Kluza, Geoff Wells, et al.
Molecular Cancer Therapeutics|February 5, 2009
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumorsClaudia Forni, Mario Minuzzo, Emanuela Virdis, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
A <i>GLB1</i> transgene with enhanced therapeutic potential for the preclinical development of <i>ex-vivo</i> gene therapy to treat mucopolysaccharidosis type IVBStefania Crippa, Gaia Alberti, Laura Passerini, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gene|January 13, 2006
The Pole3 bidirectional unit is regulated by MYC and E2FsFabrizio Bolognese, Claudia Forni, Giuseppina Caretti, et al.
Cell|January 22, 2013
Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitinationMarco Nardini, Nerina Gnesutta, Giacomo Donati, et al.
Molecular Cancer Therapeutics|January 24, 2007
Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamideDaniel Hochhauser, Minal Kotecha, Caroline O'hare, et al.
Molecular Cancer Therapeutics|May 17, 2008
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78Minal Kotecha, Jerome Kluza, Geoff Wells, et al.
Molecular Cancer Therapeutics|February 5, 2009
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumorsClaudia Forni, Mario Minuzzo, Emanuela Virdis, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
A <i>GLB1</i> transgene with enhanced therapeutic potential for the preclinical development of <i>ex-vivo</i> gene therapy to treat mucopolysaccharidosis type IVBStefania Crippa, Gaia Alberti, Laura Passerini, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Pageof 1